SciGen Ltd Buys China Rights to Generex Biotechnology Corporation Oral Insulin Spray

Published: Apr 14, 2008

April 14, 2008 -- SciGen, Ltd. (ASX: SIE), a Singapore company that trades in Australia, has licensed the China rights to Oral-lyn™, an oral insulin spray product that is being developed by Generex (NSDQ: GNBT). SciGen will supply its own recombinant human insulin product, while Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the Asia-Pacific region. More details...

Back to news